---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-029879"
form_type: "8-K"
ticker: null
cik: "0001708331"
company_name: "Virpax Pharmaceuticals, Inc."
filed_at: "2023-04-14T23:59:59+00:00"
generated_at: "2026-06-17T02:01:12.530291+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Virpax receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Nasdaq notified Virpax on April 10, 2023 of non-compliance with Listing Rule 5550(a)(2) for bid price below $1.00.
- Company has 180 calendar days, until October 9, 2023, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, Virpax may qualify for an additional 180-day period, subject to meeting other listing requirements and potential reverse stock split.

## SEC filing metadata
- accession: 0001213900-23-029879
- form_type: 8-K
- cik: 0001708331
- company_name: Virpax Pharmaceuticals, Inc.
- filed_at: 2023-04-14T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708331/000121390023029879/0001213900-23-029879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708331/000121390023029879/ea176786-8k_virpaxpharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-029879
- JSON: https://secwatch.observer/filing/0001213900-23-029879.json
- Plain text: https://secwatch.observer/filing/0001213900-23-029879.txt

## Key facts
- Listing & Compliance Notices
  Virpax Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 10, 2023, Virpax Pharmaceuticals, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid pric
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000121390023029879/0001213900-23-029879-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.